TScan Therapeutics (TCRX) Interest Coverage Ratio (2020 - 2026)

TScan Therapeutics (TCRX) has 7 years of Interest Coverage Ratio data on file, last reported at 42.29 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 20.78% year-over-year to 42.29 in Q1 2026; TTM through Mar 2026 was 41.24, a 0.43% change from a year earlier, with the FY2025 full-year figure at 1.62, up 88.25% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 42.29, down from 22.85 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for TCRX reached as high as 3.29 in Q4 2023 and fell as low as 82.48 in Q3 2022.
• Historically, Interest Coverage Ratio has averaged 36.51 across 5 years, with a median of 34.05 in 2024.
• Across the five-year window, Interest Coverage Ratio slumped 4820.96% in 2022 and jumped 69.44% in 2023, its largest moves.
• Year by year, Interest Coverage Ratio stood at 10.37 in 2022, then soared by 68.27% to 3.29 in 2023, then sank by 1323.63% to 46.83 in 2024, then jumped by 51.2% to 22.85 in 2025, then plunged by 85.06% to 42.29 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 42.29 in Q1 2026, 22.85 in Q4 2025, and 53.01 in Q3 2025.